Financials

News Ideas Discussions Technicals Forecast Seasonals

Pretax income of Zentalis Pharmaceuticals, Inc.

Annual data

2019

2020

2021

2022

2023

TTM

‪‪−280.00 M‬‬

‪‪−210.00 M‬‬

‪‪−140.00 M‬‬

‪‪−70.00 M‬‬

‪0.00‬

Period

Value

Change

Change %

TTM

‪‪−179.09 M‬‬

+‪‪97.81 M‬‬

+‪35.32‬%

2023

‪‪−276.89 M‬‬

‪‪−55.59 M‬‬

‪−25.12‬%

2022

‪‪−221.30 M‬‬

‪‪−56.74 M‬‬

‪−34.48‬%

2021

‪‪−164.56 M‬‬

‪‪−46.45 M‬‬

‪−39.33‬%

2020

‪‪−118.10 M‬‬

‪‪−71.74 M‬‬

‪−154.74‬%

2019

‪‪−46.36 M‬‬

‪‪−22.93 M‬‬

‪−97.89‬%

Quarterly data

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−105.00 M‬‬

‪‪−70.00 M‬‬

‪‪−35.00 M‬‬

‪0.00‬

‪‪35.00 M‬‬

Period

Value

Change

Change %

Q3 '24

‪‪−40.19 M‬‬

+‪‪47.83 M‬‬

+‪54.34‬%

Q2 '24

‪‪−88.01 M‬‬

‪‪−98.19 M‬‬

‪−964.29‬%

Q1 '24

‪‪10.18 M‬‬

+‪‪71.26 M‬‬

—

Q4 '23

‪‪−61.07 M‬‬

‪‪−5.57 M‬‬

‪−10.03‬%

Q3 '23

‪‪−55.51 M‬‬

+‪‪43.96 M‬‬

+‪44.19‬%

Q2 '23

‪‪−99.47 M‬‬

‪‪−38.62 M‬‬

‪−63.48‬%

Q1 '23

‪‪−60.84 M‬‬

‪‪−12.32 M‬‬

‪−25.39‬%

Q4 '22

‪‪−48.52 M‬‬

+‪‪3.77 M‬‬

+‪7.20‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20

Q4 '19

Q3 '19

Q2 '19